Pharmacogenetic Testing in Patients With Depression: A Quality Improvement Project
PGx may offer clinical value for patients with severe depression. Results should be interpreted cautiously, and further studies using validated scales and controlled designs are needed.
Authors
- Amy Spurlock (ORCID: https://orcid.org/0000-0002-4276-6480)
- Kerri L. Outlaw
- Jeremy Tyler Rockwell
Institutions
- Boise State University (US)
- Troy University (US)
- University of Alabama (US)
Publication Details
- Journal
- Journal of the American Psychiatric Nurses Association
- Published
- 2026-03-28
- DOI
- https://doi.org/10.1177/10783903261431278
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00